A Renewed Focus on Malaria in the Trump Administration’s America First Global Health Strategy
The Trump administration’s America First Global Health Strategy, unveiled in September 2025, marks a significant shift in U.S. Global health engagement, with malaria prevention and treatment emerging as a central priority. This approach follows substantial changes to foreign assistance programs, including an estimated 67% reduction in USAID global health awards and the discontinuation of support for multilateral initiatives like Gavi, the Vaccine Alliance.
Under the new strategy, bilateral Memorandums of Understanding (MOUs) with recipient countries are being rapidly negotiated to replace traditional aid models. These agreements emphasize country-led funding and sustainability, aiming to build local capacity for long-term disease control. Officials state the strategy is designed to “protect the homeland by preventing infectious disease outbreaks from reaching U.S. Shores” while advancing American interests abroad.
Malaria at a Crossroads
Malaria remains a critical global health challenge, particularly in sub-Saharan Africa, where the disease accounts for hundreds of thousands of deaths annually. The U.S. Has historically been a leading donor in the fight against malaria through initiatives like the President’s Malaria Initiative (PMI). However, recent policy shifts have created uncertainty about future funding levels and program continuity.
According to reports from March 2026, U.S. Relief efforts for malaria were significantly impacted by the restructuring of USAID programs. An 85% cut to certain USAID malaria-related activities has raised concerns among global health experts about potential setbacks in malaria elimination efforts, especially in regions with high transmission rates.
Despite these challenges, some global health leaders express cautious optimism. Bill Steiger, who served as chief of staff at USAID during the first Trump administration and now leads the nonprofit Malaria No More, has publicly endorsed the current administration’s approach. He characterizes the dramatic changes to global health architecture as “a long time in coming” and supports the emphasis on accelerating “the journey to self-reliance” in partner nations.
Shifting Toward Country-Led Models
The America First strategy prioritizes direct bilateral engagement over traditional multilateral channels. By negotiating MOUs with individual countries, the administration aims to ensure that U.S. Health assistance aligns with national priorities and fosters greater accountability. This model requires recipient governments to increase their own financial contributions to health programs over time, reducing long-term dependency on foreign aid.
Proponents argue this approach leads to more sustainable health systems and better outcomes. Critics, however, warn that abrupt funding reductions could disrupt ongoing malaria control programs, including insecticide-treated net distribution, indoor residual spraying, and access to rapid diagnostic tests and artemisinin-based combination therapies.
The Path Forward
As of April 2026, the administration continues to finalize bilateral agreements across multiple partner nations. The success of this strategy will depend on whether country-led models can maintain or improve upon the coverage and effectiveness of previous U.S.-supported malaria interventions while building resilient local health systems.
Global health advocates stress that sustained political commitment and adequate resources remain essential to achieving the goal of malaria elimination. Whether the America First approach can deliver these outcomes is now being closely monitored by policymakers, implementers, and affected communities worldwide.